Cetuximab for metastatic colorectal cancer (mCRC), from ASCO 2008
Published: 27 Nov 2008
Views: 15764
Professor Carsten Bokemeyer
- Categories:
- Colorectal & gastro
Related Videos
Oesophageal and gastric cancers
Dr Mike Cusnir - Mount Sinai Medical Center, Florida, USA
28 Jul 2021
BEACON-CRC: first-line bevacizumab in colorectal cancer treatment
Prof Dan Aderka - Tel-Aviv University, Tel-Aviv, Israel
26 Jul 2021
OncoAlert and ecancer weekly round up for July 12- July 18, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
19 Jul 2021
Cell free DNA BRAF mutant allele fraction and whole exome sequencing in BRAFV600...
Dr Elena Elez - Vall d'Hebron University Hospital, Barcelona, Spain
13 Jul 2021
OncoAlert and ecancer weekly round up for July 1- July 10, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
13 Jul 2021
Study of the anti-TIGIT antibody tiragolumab in combination with atezolizumab in...
Dr Zev Wainberg - University of California Los Angeles, California, USA
12 Jul 2021
Pembrolizumab plus trastuzumab and chemotherapy for HER2+ metastatic gastric or ...
Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA
14 Jun 2021
Pembrolizumab improves on chemo in MSI-H/dMMR mCRC
Prof Thierry André - Sorbonne University and Saint-Antoine Hospital, Paris, Fran...
11 Jun 2021
CHRONOS: Anti-EGFR rechallenge therapy with panitumumab driven by ctDNA molecula...
Prof Andrea Sartore-Bianchi - Ospedale Niguarda, Milan, Italy
10 Jun 2021
